The role of Labrasol® in the enhancement of the cutaneous bioavailability of minoxidil in phospholipid Vesicles

Research Journal of Pharmacy and Technology

Volumn 5, Issue 12, 2012, Pages 1563-1569

  Caddeo, Carla ^a   Manconi, Maria ^a   Valenti, Donatella ^a   Maccioni, Anna Maria ^a   Fadda, Anna Maria ^a   Sinico, Chiara ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Labrasol; Minoxidil; P50 vesicles; Penetration enhancer; Skin penetration

Indexed keywords

FATTY ACID; LABRASOL; MINOXIDIL; NANOCARRIER; PENETRATION ENHANCING AGENT; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG COST; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; EX VIVO STUDY; HYDRATION; NONHUMAN; PHOSPHOLIPID VESICLE; PHYSICAL CHEMISTRY; SWINE; ULTRASOUND;

EID: 84871588317     PISSN: 0974360X     EISSN: 09743618     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mura S et al. Penetration enhancer containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 380; 2009: 72-79.
2. Mura P et al. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm. 67; 2007: 86-95.
3. Balakrishnan P et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm. 377; 2009: 1-8.
4. López-Pinto JM, González-Rodríguez ML and Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 298; 2005: 1-12.
5. Silva AC et al. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie. 64; 2009: 177-182.
6. Gelfuso GM et al. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate. J Microencapsulation. 28; 2011: 650-658.
7. Paolino D et al. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. Biomed Microdevices. 9; 2007: 421-33.
8. Dragicevic-Curic N et al. Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release. 127; 2008: 59-69.
9. Muzzalupo R et al. Niosomes from alpha, omega-trioxyethylenebis(sodium2-dodecyloxy-propylenesulfonate): Preparation and characterization. Colloid Surf B-Biointerfaces. 64; 2008: 200-207.
10. Tavano L et al. Effect of formulations variables on the in vitro percutaneous permeation of Sodium Diclofenac from new vesicular systems obtained from Pluronic triblock copolymers. Colloid Surf B-Biointerfaces. 79; 2010: 227-234.
11. Gupta M, Agrawal U and Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv. 9; 2012: 783-804.
12. Elmoslemany RM et al. Propylene Glycol Liposomes as a Topical Delivery System for Miconazole Nitrate: Comparison with Conventional Liposomes. AAPS Pharm Sci Tech. 13; 2012: 723-731.
13. ®containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomed Microdevices. 14; 2012: 119-30.
14. Kumar GP and Rao PR. Ultra deformable niosomes for improved transdermal drug delivery: The future scenario. Asian J Pharm Scie. 7; 2012: 96-109.
15. Mura S et al. Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target. 19; 2011: 189-196.
16. Manconi M et al. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. Eur J Pharm Biopharm. 78; 2011: 27-35.
17. Chessa M et al. Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics. 3; 2011: 497-509.
18. Manconi M et al. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 412; 2011: 37-46.
19. Manconi M et al. Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability. Eur J Pharm Biopharm. 82; 2012: 352-359.
20. Chantasart D and Li SK. Structure Enhancement Relationship of Chemical Penetration Enhancers in Drug Transport across the Stratum Corneum. Pharmaceutics. 4; 2012: 71-92.
21. Manconi M et al. Intracellular distribution of fluorescent probes delivered by vesicles of different lipidic composition. Colloid Surf B-Biointerfaces. 57; 2007: 143-151.
22. Bragagni M et al. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting. J Pharm Pharm Sci. 15; 2012: 184-196.
23. Marianecci C et al. A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization. J Pharm Pharm Sci. 14; 2011: 336-346.
24. El Maghraby GM, Williams AC and Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol. 53; 2001: 1069-1077.
25. Trotta M et al. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm. 241; 2002: 319-327.
26. Elsayed MMA et al. PG-liposomes: a novel lipid vesicles for skin delivery of drug. J Pharm Pharmacol. 59; 2007: 447-1450.
27. Sinico C and Fadda AM. Liposomes and niosomes as carriers for dermal drug delivery. Expert Opin Drug Deliv. 6; 2009: 813-825.
28. Verma DD et al. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm. 55; 2003: 271-277.
29. Elsayed MM et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 322; 2006: 60-66.
30. Manconi M et al. Development and characterization of liposomes containing glycols as carriers for diclofenac. Colloid Surf A-Physicochem Eng Asp. 342; 2009: 53-58.